Oncorena is aiming to save human lives by transforming a natural substance into a breakthrough therapy treatment for advanced kidney cancer. We have completed all preclinical studies and are moving into early-stage clinical development. The objective is to confirm the powerful anti-tumor activity of our drug candidate - based on the natural substance orellanine - in advanced kidney cancer patients. Oncorena AB is headquartered in Lund, Sweden.
| Website | http://www.oncorena.com |
| Revenue | $811000 |
| Employees | 14 (3 on RocketReach) |
| Founded | 2011 |
| Address | 1 Medicon Village Scheeletorget, Lund, Skane 223 81, SE |
| Phone | +46 70 664 94 77 |
| Technologies |
JavaScript
,
HTML
,
PHP
+6 more
(view full list)
|
| Industry | Pharmaceutical Manufacturing, Drug Manufacturing & Research, Health Care, Pharmaceuticals, Therapeutics, Healthcare |
| Keywords | Cancer Treatment, Oncology, Clinical Development, Cancer Research, Novel Therapy, Clinical Trials, Preclinical Studies, Pharmaceutical Research, Targeted Therapy, Medical Innovation, Drug Development, Biotechnology, Immunotherapy, Cancer Drugs, Therapeutic Solutions |
| Competitors | Roche, Novartis, Merck AH, Pfizer, GSK, AstraZeneca, Bristol Myers Squibb, Amgen, Gilead Sciences, Lilly India +42 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 32541 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies |
Looking for a particular Oncorena AB employee's phone or email?
The Oncorena AB annual revenue was $811000 in 2026.
Susanna Dahlgren is the COO of Oncorena AB.
3 people are employed at Oncorena AB.
Oncorena AB is based in Lund, Skane.
The NAICS codes for Oncorena AB are [32541, 3254, 325, 32].
The SIC codes for Oncorena AB are [283, 28].